A phase I study of TRC105 anti-endoglin ( CD 105) antibody in metastatic castration-resistant prostate cancer
58 citations
FWCI 4.95
Prostate Cancer Treatment and Research
Trend
Citation data as of 2026-04-12 (OpenAlex).
Extracted findings
This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 6596291 is in the queue.